Cargando…
Patient-reported diagnostic intervals to colorectal cancer diagnosis in the Midland region of New Zealand: a prospective cohort study
BACKGROUND AND OBJECTIVES: New Zealand (NZ) has high rates of colorectal cancer (CRC) but low rates of early detection. The majority of CRC is diagnosed through general practice, where lengthy diagnostic intervals are common. We investigated factors contributing to diagnostic delay in a cohort of pa...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295611/ https://www.ncbi.nlm.nih.gov/pubmed/34871389 http://dx.doi.org/10.1093/fampra/cmab155 |
_version_ | 1784750085027921920 |
---|---|
author | Blackmore, Tania Chepulis, Lynne Rawiri, Keenan Kidd, Jacquie Stokes, Tim Firth, Melissa Elwood, Mark Weller, David Emery, Jon Lawrenson, Ross |
author_facet | Blackmore, Tania Chepulis, Lynne Rawiri, Keenan Kidd, Jacquie Stokes, Tim Firth, Melissa Elwood, Mark Weller, David Emery, Jon Lawrenson, Ross |
author_sort | Blackmore, Tania |
collection | PubMed |
description | BACKGROUND AND OBJECTIVES: New Zealand (NZ) has high rates of colorectal cancer (CRC) but low rates of early detection. The majority of CRC is diagnosed through general practice, where lengthy diagnostic intervals are common. We investigated factors contributing to diagnostic delay in a cohort of patients newly diagnosed with CRC. METHODS: Patients were recruited from the Midland region and interviewed about their diagnostic experience using a questionnaire based on a modified Model of Pathways to Treatment framework and SYMPTOM questionnaire. Descriptive statistics were used to describe the population characteristics. Chi-square analysis and logistic regression were used to analyse factors influencing diagnostic intervals. RESULTS: Data from 176 patients were analysed, of which 65 (36.9%) experienced a general practitioner (GP) diagnostic interval of >120 days and 96 (54.5%) experienced a total diagnostic interval (TDI) > 120 days. Patients reporting rectal bleeding were less likely to experience a long TDI (odds ratio [OR] 0.34, 95% confidence interval [CI]: 0.14–0.78) and appraisal/help-seeking interval (OR, 0.19, 95% CI: 0.06–0.59). Patients <60 were more likely to report a longer appraisal/help-seeking interval (OR, 3.32, 95% CI: 1.17–9.46). Female (OR, 2.19, 95% CI: 1.08–4.44) and Māori patients (OR, 3.18, 95% CI: 1.04–9.78) were more likely to experience a long GP diagnostic interval. CONCLUSION: NZ patients with CRC can experience long diagnostic intervals, attributed to patient and health system factors. Young patients, Māori, females, and patients experiencing change of bowel habit may be at particular risk. We need to increase symptom awareness of CRC for patients and GPs. Concentrated efforts are needed to ensure equity for Māori in access to screening, diagnostics, and treatment. |
format | Online Article Text |
id | pubmed-9295611 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-92956112022-07-20 Patient-reported diagnostic intervals to colorectal cancer diagnosis in the Midland region of New Zealand: a prospective cohort study Blackmore, Tania Chepulis, Lynne Rawiri, Keenan Kidd, Jacquie Stokes, Tim Firth, Melissa Elwood, Mark Weller, David Emery, Jon Lawrenson, Ross Fam Pract Health Service Research BACKGROUND AND OBJECTIVES: New Zealand (NZ) has high rates of colorectal cancer (CRC) but low rates of early detection. The majority of CRC is diagnosed through general practice, where lengthy diagnostic intervals are common. We investigated factors contributing to diagnostic delay in a cohort of patients newly diagnosed with CRC. METHODS: Patients were recruited from the Midland region and interviewed about their diagnostic experience using a questionnaire based on a modified Model of Pathways to Treatment framework and SYMPTOM questionnaire. Descriptive statistics were used to describe the population characteristics. Chi-square analysis and logistic regression were used to analyse factors influencing diagnostic intervals. RESULTS: Data from 176 patients were analysed, of which 65 (36.9%) experienced a general practitioner (GP) diagnostic interval of >120 days and 96 (54.5%) experienced a total diagnostic interval (TDI) > 120 days. Patients reporting rectal bleeding were less likely to experience a long TDI (odds ratio [OR] 0.34, 95% confidence interval [CI]: 0.14–0.78) and appraisal/help-seeking interval (OR, 0.19, 95% CI: 0.06–0.59). Patients <60 were more likely to report a longer appraisal/help-seeking interval (OR, 3.32, 95% CI: 1.17–9.46). Female (OR, 2.19, 95% CI: 1.08–4.44) and Māori patients (OR, 3.18, 95% CI: 1.04–9.78) were more likely to experience a long GP diagnostic interval. CONCLUSION: NZ patients with CRC can experience long diagnostic intervals, attributed to patient and health system factors. Young patients, Māori, females, and patients experiencing change of bowel habit may be at particular risk. We need to increase symptom awareness of CRC for patients and GPs. Concentrated efforts are needed to ensure equity for Māori in access to screening, diagnostics, and treatment. Oxford University Press 2021-12-06 /pmc/articles/PMC9295611/ /pubmed/34871389 http://dx.doi.org/10.1093/fampra/cmab155 Text en © The Author(s) 2021. Published by Oxford University Press. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Health Service Research Blackmore, Tania Chepulis, Lynne Rawiri, Keenan Kidd, Jacquie Stokes, Tim Firth, Melissa Elwood, Mark Weller, David Emery, Jon Lawrenson, Ross Patient-reported diagnostic intervals to colorectal cancer diagnosis in the Midland region of New Zealand: a prospective cohort study |
title | Patient-reported diagnostic intervals to colorectal cancer diagnosis in the Midland region of New Zealand: a prospective cohort study |
title_full | Patient-reported diagnostic intervals to colorectal cancer diagnosis in the Midland region of New Zealand: a prospective cohort study |
title_fullStr | Patient-reported diagnostic intervals to colorectal cancer diagnosis in the Midland region of New Zealand: a prospective cohort study |
title_full_unstemmed | Patient-reported diagnostic intervals to colorectal cancer diagnosis in the Midland region of New Zealand: a prospective cohort study |
title_short | Patient-reported diagnostic intervals to colorectal cancer diagnosis in the Midland region of New Zealand: a prospective cohort study |
title_sort | patient-reported diagnostic intervals to colorectal cancer diagnosis in the midland region of new zealand: a prospective cohort study |
topic | Health Service Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295611/ https://www.ncbi.nlm.nih.gov/pubmed/34871389 http://dx.doi.org/10.1093/fampra/cmab155 |
work_keys_str_mv | AT blackmoretania patientreporteddiagnosticintervalstocolorectalcancerdiagnosisinthemidlandregionofnewzealandaprospectivecohortstudy AT chepulislynne patientreporteddiagnosticintervalstocolorectalcancerdiagnosisinthemidlandregionofnewzealandaprospectivecohortstudy AT rawirikeenan patientreporteddiagnosticintervalstocolorectalcancerdiagnosisinthemidlandregionofnewzealandaprospectivecohortstudy AT kiddjacquie patientreporteddiagnosticintervalstocolorectalcancerdiagnosisinthemidlandregionofnewzealandaprospectivecohortstudy AT stokestim patientreporteddiagnosticintervalstocolorectalcancerdiagnosisinthemidlandregionofnewzealandaprospectivecohortstudy AT firthmelissa patientreporteddiagnosticintervalstocolorectalcancerdiagnosisinthemidlandregionofnewzealandaprospectivecohortstudy AT elwoodmark patientreporteddiagnosticintervalstocolorectalcancerdiagnosisinthemidlandregionofnewzealandaprospectivecohortstudy AT wellerdavid patientreporteddiagnosticintervalstocolorectalcancerdiagnosisinthemidlandregionofnewzealandaprospectivecohortstudy AT emeryjon patientreporteddiagnosticintervalstocolorectalcancerdiagnosisinthemidlandregionofnewzealandaprospectivecohortstudy AT lawrensonross patientreporteddiagnosticintervalstocolorectalcancerdiagnosisinthemidlandregionofnewzealandaprospectivecohortstudy |